Compare Huntington Ingalls Industries Inc (HII) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Ingalls Industries Inc vs Immunovant Inc. Common Stock — how do they compare? Huntington Ingalls Industries Inc trades at $265 (market cap $10.27B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Huntington Ingalls Industries Inc is the larger of the two by market cap, and Huntington Ingalls Industries Inc pays a 2.12% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Huntington Ingalls Industries Inc for 28 Days and Immunovant Inc. Common Stock for 0 Days on average.
| HII | IMVT | |
|---|---|---|
Market Cap | $10.27B | $6.62B |
Volume | 554,386 | 1,131,364 |
Sector | Industrials | Health |
52-Week High | $453.73 | $44.96 |
52-Week Low | $257.05 | $17.03 |
Typical Hold Time | 28 Days | 0 Days |
Enterprise Value | $13.19B | $5.72B |
Dividend Yield | 2.12% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HII trades at $260.67, down 1.17% on the day, amid a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $5.27 exceeding expectations. Recent news highlights contract wins, including a $5.1 billion aircraft carrier overhaul and expansion in unmanned systems, supporting a $57.3 billion backlog. Valuation ratios appear reasonable with a P/E of 15.53 and P/S of 0.78.
The outlook is supported by robust defense budgets and contract momentum, but risks include execution on large projects and market sentiment. Analysts are mixed with a 40.7% buy rating and a consensus price target of $363.67, suggesting significant upside potential from current levels if operational performance continues.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
